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Despite exponential growth in the
past decades, most aspects of the assisted reproductive technology (ART)
industry remain largely unregulated;
recently, pressure has been mounting for coordinated study and regulation of this developing industry.' On
March 28, 2008, lawyers, health care
professionals, representatives from
sperm banks, consumers of ART services, and other stakeholders in ART
industry gathered at DePaul University College of Law for its Health Law
Institute's symposium titled "Tracking Change: The Feasibility of a Voluntary Gamete Donor Registry in the
United States." The implementation
of a registry would mark the first effort in the United States to centralize,
maintain, and disseminate information about gamete donors by collecting and storing genetic and identifying information about egg and
sperm donors.2 Establishing a registry requires balancing the interests
of donor-conceived individuals, their
parents, gamete donors, health care
professionals, and society as a whole,
as well as ensuring the privacy and
safety of all involved. Further, the
consideration of a voluntary registry
invites debate about the desirability
of a mandatory registry and increased
systematic consideration and regulation of ART generally.
Background
Currently, it is impossible to know the
exact number of donor-conceived individuals in the United States because
no federal, state, or private agency
tracks donor-conceived births. 4 The
ART industry in the United States
is regulated primarily by voluntary
guidelines issued by organizations
such as the American Society for
Reproductive Medicine (ASRM); as
these guidelines are advisory only,
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the extent to which they are followed
is unclear.5 There are few federal or
state regulations, and those that do
exist are not comprehensive. 6 Thus,
the result is a decentralized, private
industry that has yielded a norm of
anonymous gamete donation, an absence of information about the intricacies of the market for gametes and
the effects of ART, confusion about
the legal consequences of gamete donation, inconsistent record keeping
of births, and a dearth of resources
for donor-conceived individuals in
7
search oftheir biological progenitors.
Nowhere is this result more evident
than in the realm of gamete donation: there are 26 sperm banks (five
of which supply 75-80% of sperm
distributed) and several hundred egg
donor programs in the United States,
most operating according to their
own standards. An accurate estimate
of the number of egg donor programs
is impossible as no registration, licensing, or other requirements exist
to track such entities."
In contrast to the United States'
model, many other countries heavily
regulate ART, including mandating
the non-anonymity of donors. 9 Historically, the United States' norm of
donor anonymity and overall lack of
regulation of ART reflected infertility's stigma, a national emphasis on
personal autonomy and privacy, and
a heated political debate over abortion. 10 Nevertheless, in recent years,
the desirability of anonymous gamete
donation has come into question, especially with regard to the interests
of donor-conceived individuals (and
their parents) in learning about their
genetic origins." Donors themselves
also have advocated for open-identity
donation, indicating an interest in
knowing the outcome of their donation and a willingness to have contact with offspring. 2 This change in
the perspective of ART participants
has resulted in the following: (1)
prompted the ASRM to promulgate
guidelines advocating the collection
and distribution of donors' genetic
information upon request to donorconceived individuals and their parents; 13 (2) led to the creation of Web
sites dedicated to linking donor-conceived children with their genetic
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half-siblings and donor "parents"
if all parties are in agreement; 14 (3)
encouraged sperm banks to establish
open-identity donor programs that
operate alongside anonymous donation programs; 15 and (4) fostered an
increase in the ratio of open-identity
to anonymous donors.'6
Overall, there has been a trend toward open-identity donation, a term
that describes gamete donors who
agree to release their identifying information to their offspring when
those offspring reach adulthood. As
noted at the symposium, there also
has been a recognition that all participants in the gamete donation process
may have an interest in the collection,

of information that a registry would
facilitate and provided a forum for
the key stakeholders to discuss the
benefits, drawbacks, and design of a
voluntary registry.
The symposium's participants primarily examined how a registry might
be designed to ensure that donorconceived individuals' (or their parents') desire to access their biological
progenitors might be advanced while
protecting the interests of donors
and parents. Even enabling this unidirectional exchange of information
between donor-conceived individuals
and their biological progenitors has
the potential to generate benefits for
many more stakeholders. Assuming

Moreover, the societal benefits
that may accrue from such a registry
are immense. For example, tracking gamete donation could address
a concern about inadvertent consanguinity.2 0 Beyond identifying geneti-

cally related individuals by following who is donating gametes where
and when and the outcome of ART
cycles using those gametes, health
care professionals and researchers
could draw upon information contained in a registry to generate data
to better study the effects of ART on
consumers of ART services, donors,
and offspring. An improved understanding of ART may provide empirical grounds for the establishment of

An improved understanding of ART may provide empirical grounds for
the establishment of national standards for gamete donors and individuals
undergoing ART procedures, limits on the number of children created
by one individual's gametes, limits on how many times or how frequently
one individual may donate gametes, and regulation of the solicitation and
compensation of gamete donors. Further, a registry may increase society's
confidence in and acceptance of gamete donation, while simultaneously
recognizing its uniqueness as a means to facilitate procreation.
maintenance, and disclosure of information about gamete donors. The
confluence of these developments is
why "Tracking Change" assembled
key stakeholders in the ART industry
to debate the creation of a national
voluntary gamete registry.
Benefits, Drawbacks, and
Feasibility of a Registry
One of the main impetuses to creating a national voluntary gamete registry is donor-conceived individuals'
(or their parents') desire to access information about their genetic origins.
However, a registry would not merely
be a place for donor-conceived individuals to go in search of their genetic
origins, but it would also be a central
database of information for health
care professionals, researchers, consumers of ART services, donors, and
half-siblings. "Tracking Change" focused on the multi-directional flow

donor-conceived individuals know
they are donor conceived, accessing
such information may advance their
psychological well-being and sense of
self. Similarly, if desired by all parties involved, the information could
facilitate the connection and possible
meeting of donors and genetic halfsiblings, likewise improving the psychological well-being of donors and
genetic half-siblings. A registry also
could provide updated medical information about a donor's offspring and
genetic half-siblings, which would
provide an added medical - in addition to psychological - benefit for
these parties. 8 Though medical information is routinely collected from
donors at the time of donation, this
information is rarely updated; medical history is almost never collected
from donor-conceived individuals
for use by their donors and genetic
half-siblings. 9

national standards for gamete donors
and individuals undergoing ART
procedures, limits on the number of
children created by one individual's
gametes, limits on how many times
or how frequently one individual may
donate gametes, and regulation of
the solicitation and compensation of
gamete donors. Further, a registry
may increase society's confidence in
and acceptance of gamete donation,
while simultaneously recognizing its
uniqueness as a means to facilitate
procreation, thus responding to ethical arguments about the commodification that may accompany gamete
donation and ART. This may in turn
result in reduction of the
stigma as2
sociated with infertility. '
Realizing these personal and societal benefits requires negotiating the
potentially adverse interests of donors
and the parents of donor-conceived
individuals. Legally, donors may have
JOURNAL OF LAW, MEDICINE & ETHICS
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a right to prevent disclosure of their
identifying information, and disclosure may violate the recipient parents'
privacy. Conflictingly, donor-conceived individuals may have a right to
know information about themselves
under certain circumstances. Though
a gamete registry could be designed
to address donors' privacy concerns
by allowing the disclosure of donors'
identifying information only upon
their approval or precluding contact
without their consent, donors' significant concerns about their parentage
status remain. A majority of states do
have laws relieving sperm donors of
parental rights so long as the intended
parent(s) have consented, but only a
few states have enacted similar legislation addressing egg and embryo
donation. Further, even if donors are
willing to submit their information to
a registry, the lack of well-established
and tested regulations may dissuade
22
participation.

Disincentives from uncertain legal
regimes is but one of a number of
barriers to implementation of a registry. The tension between intended
parents' privacy and the ability of
donor-conceived individuals to access their genetic origins raises the
question of how children might learn
that they are donor-conceived in the
first place, which was largely beyond
the symposium's scope. Additionally,
though a registry may provide health
care professionals with greater information about how ART affects their
patients, thereby allowing them to
better inform and follow-up with patients, health care professionals note
that a registry may intrude upon the
practice of medicine. For example, it
may increase the already high cost of
ART, pricing more people out of these
services; it may decrease the availability of gametes by reducing donations;
and it may encourage international
reproductive travel.

23

Logistical implementation issues
also must be resolved. Open questions include who will be responsible
for gathering information and ensuring its protection, how data will be
verified, and what should be done
with outdated records. 24 Though no

concrete proposal for a voluntary registry was discussed at the symposium,

the three largest sperm banks in the
United States have advocated for the
creation of a voluntary registry run
by a non-profit entity governed by a
board of directors elected by its members, who will fund the non-profit and
be comprised of sperm banks and egg
donation programs.25 Yet, funding
sources are influential, which leads
others to question the appropriateness of vesting regulation in the in6
dustry being regulated.2
Overall, symposium participants
agreed that even if the implementation issues associated with a purely
voluntary registry prevent the full realization of the potential societal and
personal benefits discussed, the creation of a voluntary national gamete
registry is a step in the right direction
when compared with the status quo
of sparsely regulated and sporadic record keeping.
What Should Voluntary Mean,
and Is a Mandatory Registry
Desirable?
Questions about implementation
led some participants to assert that
a mandatory registry is necessary, although the symposium's participants
only briefly discussed the relative
merits of a mandatory versus a voluntary registry. Some time was spent
considering the related question of
what "voluntary" should mean. The
medical or psychological benefits that
donor-conceived individuals might
experience could be undermined
if parties opt-out at any one of several moments in a purely voluntary
scheme. Some sperm banks and egg
donor programs may decline to participate in the registry, and donors
within a participating program may
themselves decline to provide information or may choose to provide only
partial information. For example, a
donor-conceived individual would
only be able to access her genetic information or connect with her biological relative(s) if her parents chose
a fully participating donor from a
participating program. Further, the
larger societal benefits noted above
have little chance of being realized
without a guarantee that a threshold
level of information will be collected
and maintained.
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A mandatory registry would ensure
that donor-conceived individuals
are able to access information about
their biological origins while protecting the privacy of donors by including safeguards concerning when
and how donors may be contacted.
Moreover, a mandatory registry may
prompt federal and state legislators
to enact statutes to resolve legal issues surrounding ART. Finally, a
mandatory registry would guarantee
that health care professionals and
researchers have robust information
to consult when studying ART techniques. 27 However, given the United
States' strong emphasis on personal
autonomy and privacy, even if a mandatory registry is desirable, it may not
be politically realistic.
Potential Impact on the Assisted
Reproductive Technology Industry
As the first real national response
to any consumer aspect of the ART
industry, the mere proposal of a
national registry has the potential
to impact the ART industry far
beyond providing for the needs of
the donor-conceived individuals who
initially motivated its suggestion,
thus highlighting other aspects of the
ART industry that invite systematic
consideration and regulation.
Although a discussion of these other
aspects was almost entirely beyond
the scope of "Tracking Change," it
is interesting to hypothesize about
some possible impacts of a registry
on the ART industry that were only
referenced in passing or not raised at
the symposium.
In discussing the ART industry,
commentators have focused on the
consumers of ART services, 2 ART's
corollaries with and effects on adoption, 29 and class inequalities in access
to ART30 as aspects of the industry
that could benefit from increased
regulation. Additionally, the need for
counseling of all participants in the
ART process was specifically mentioned at the symposium. But perhaps the most important consequence
of increased discussion of ART is the
potential to improve recognition of
how most aspects of ART, especially
egg donation, affect women. Egg donation is complicated, painful, and
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potentially life-threatening21 With
several hundred egg donor programs
in the United States, it is virtually impossible to ensure that every woman
who donates eggs is fully informed
about the dangers of the procedure
and that egg donation programs are
taking the necessary safety precautions. Moreover, women themselves
have become commercialized and
sexualized apart from the eggs they
donate, vastly more so than sperm
donors. 32 Not only do select college students' eggs fetch upwards
of $100,000,33 an existing Web site
offers the opportunity to bid on the
eggs of the female models whose
pornographic pictures members pay
a monthly fee to view.34 Such high
monetary values placed on certain
women's eggs engenders questions
about the frequency with which some
women donate eggs, which may bring
both physical and mental health risks
5
of its own
Further, little research has been
conducted regarding the effects of
multiple cycles of ART, multifetal
pregnancies, and multifetal pregnancy reduction on a woman's body
and psyche. 36 While a registry may
provide a forum for data collection
that will aid research into the effects
of ART techniques, it has a much
greater potential to highlight egg
donation practices as purchasers of
eggs consider obtaining eggs from a
donor that participates in the registry, especially now that eggs can be
frozen and the egg market increasingly resembles the impersonal
sperm market. 37 Though there is a
possibility that the conditions of egg
procurement could become more obscured and worrisome, this transition
to an impersonal market more likely
will cause egg donor programs that
participate in the national registry to
be the primary places egg purchasers
obtain open-identity donated eggs, a
result that will encourage more uniform scrutiny and verification of the
how those eggs were obtained.
Any sustained direct focus on how
ART affects its many stakeholders has
the potential to be extremely valuable.
"Tracking Change" centered on the
benefits of a national voluntary gamete registry to donor-conceived indi-

600

viduals in search of their biological
origins and to other stakeholders who
may access the information in the
registry. Entwined in the discussion
of how best to implement a registry to
achieve those benefits is a broader debate about the regulation of the ART
industry. The creation of a voluntary
registry has the potential to advance
the interests of donor-conceived individuals, their parents, gamete donors,
and health care professionals, and in
doing so, to highlight other aspects of
the ART industry that are in need of
systematic consideration at a time of
rapid technological innovation.
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BIOETHICS FELLOWSHIP
AT THE NATIONAL
INSTITUTES OF HEALTH - DHHS
The Department of Bioethics invites
individuals with MD, PhD, JD, or
other relevant graduate training to
apply for its two-year postdoctoral
fellowship program beginning in
September 2009. Fellows will study
and participate in research related
to the ethics of clinical medicine,
health policy, human subject research,
genetics, or other bioethical fields
of interest. For a typical fellow, this
research yields multiple publications
in premier academic journals.
Fellows will participate in bioethics
seminars, case conferences, ethics
consultation, IRB deliberations,a
clinical research training course and
multiple educational opportunities at
the NIH. Applications should include
CV, 1000-word statement of interest,
official transcript, writing sample
not to exceed 30 pages collectively,
and three letters of reference.
Application deadline: RECEIVED
BY DECEMBER 31, 2008. Send
applications to Becky Chen, Bioethics,
NIH, 10 Center Dr., 10/1C118,
Bethesda, MD 20892-1156.
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